Advertisement
UK markets close in 2 hours 18 minutes
  • FTSE 100

    8,442.15
    +60.80 (+0.73%)
     
  • FTSE 250

    20,702.45
    +171.15 (+0.83%)
     
  • AIM

    790.53
    +6.83 (+0.87%)
     
  • GBP/EUR

    1.1624
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    50,282.27
    +1,216.35 (+2.48%)
     
  • CMC Crypto 200

    1,304.60
    -53.41 (-3.93%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • CRUDE OIL

    79.59
    +0.33 (+0.42%)
     
  • GOLD FUTURES

    2,368.80
    +28.50 (+1.22%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,788.50
    +101.90 (+0.55%)
     
  • CAC 40

    8,237.89
    +50.24 (+0.61%)
     

Global Percutaneous Nephrolithotomy Market to Reach $307.5 Million by 2027

Abstract: - Global Percutaneous Nephrolithotomy Market to Reach $307. 5 Million by 2027. - Amid the COVID-19 crisis, the global market for Percutaneous Nephrolithotomy estimated at US$221.

New York, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Percutaneous Nephrolithotomy Industry" - https://www.reportlinker.com/p06032472/?utm_source=GNW
2 Million in the year 2020, is projected to reach a revised size of US$307.5 Million by 2027, growing at a CAGR of 4.8% over the period 2020-2027.
- The U.S. Market is Estimated at $59.7 Million, While China is Forecast to Grow at 7.8% CAGR
- The Percutaneous Nephrolithotomy market in the U.S. is estimated at US$59.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$64.7 Million by the year 2027 trailing a CAGR of 7.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

- Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation

  • Cook Medical

  • Electro Medical Systems SA

  • innoMedicus AG

  • Karl Storz Se & Co. KG

  • Olympus Corporation

  • PolyDiagnost




Read the full report: https://www.reportlinker.com/p06032472/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Percutaneous
Nephrolithotomy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Percutaneous Nephrolithotomy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Percutaneous
Nephrolithotomy by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 4: USA Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 5: USA Historic Review for Percutaneous Nephrolithotomy
by Segment - Percutaneous Nephrolithotomy Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

CANADA
Table 6: Canada Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 7: Canada Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

JAPAN
Table 8: Japan Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 9: Japan Historic Review for Percutaneous Nephrolithotomy
by Segment - Percutaneous Nephrolithotomy Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

CHINA
Table 10: China Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 11: China Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

EUROPE
Table 12: Europe Current & Future Analysis for Percutaneous
Nephrolithotomy by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 13: Europe Historic Review for Percutaneous
Nephrolithotomy by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 14: Europe 15-Year Perspective for Percutaneous
Nephrolithotomy by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

FRANCE
Table 15: France Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 16: France Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

GERMANY
Table 17: Germany Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 18: Germany Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

ITALY
Table 19: Italy Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 20: Italy Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

UNITED KINGDOM
Table 21: UK Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 22: UK Historic Review for Percutaneous Nephrolithotomy
by Segment - Percutaneous Nephrolithotomy Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

SPAIN
Table 23: Spain Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 24: Spain Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

RUSSIA
Table 25: Russia Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 26: Russia Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

REST OF EUROPE
Table 27: Rest of Europe Current & Future Analysis for
Percutaneous Nephrolithotomy by Segment - Percutaneous
Nephrolithotomy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 28: Rest of Europe Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

ASIA-PACIFIC
Table 29: Asia-Pacific Current & Future Analysis for
Percutaneous Nephrolithotomy by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 30: Asia-Pacific Historic Review for Percutaneous
Nephrolithotomy by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 31: Asia-Pacific 15-Year Perspective for Percutaneous
Nephrolithotomy by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

AUSTRALIA
Table 32: Australia Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 33: Australia Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

INDIA
Table 34: India Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 35: India Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

SOUTH KOREA
Table 36: South Korea Current & Future Analysis for
Percutaneous Nephrolithotomy by Segment - Percutaneous
Nephrolithotomy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 37: South Korea Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

REST OF ASIA-PACIFIC
Table 38: Rest of Asia-Pacific Current & Future Analysis for
Percutaneous Nephrolithotomy by Segment - Percutaneous
Nephrolithotomy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 39: Rest of Asia-Pacific Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

LATIN AMERICA
Table 40: Latin America Current & Future Analysis for
Percutaneous Nephrolithotomy by Geographic Region - Argentina,
Brazil, Mexico and Rest of Latin America Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 41: Latin America Historic Review for Percutaneous
Nephrolithotomy by Geographic Region - Argentina, Brazil,
Mexico and Rest of Latin America Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 42: Latin America 15-Year Perspective for Percutaneous
Nephrolithotomy by Geographic Region - Percentage Breakdown of
Value Sales for Argentina, Brazil, Mexico and Rest of Latin
America Markets for Years 2012, 2020 & 2027

ARGENTINA
Table 43: Argentina Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 44: Argentina Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

BRAZIL
Table 45: Brazil Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 46: Brazil Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

MEXICO
Table 47: Mexico Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 48: Mexico Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

REST OF LATIN AMERICA
Table 49: Rest of Latin America Current & Future Analysis for
Percutaneous Nephrolithotomy by Segment - Percutaneous
Nephrolithotomy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Rest of Latin America Historic Review for
Percutaneous Nephrolithotomy by Segment - Percutaneous
Nephrolithotomy Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

MIDDLE EAST
Table 51: Middle East Current & Future Analysis for
Percutaneous Nephrolithotomy by Geographic Region - Iran,
Israel, Saudi Arabia, UAE and Rest of Middle East Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 52: Middle East Historic Review for Percutaneous
Nephrolithotomy by Geographic Region - Iran, Israel, Saudi
Arabia, UAE and Rest of Middle East Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 53: Middle East 15-Year Perspective for Percutaneous
Nephrolithotomy by Geographic Region - Percentage Breakdown of
Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of
Middle East Markets for Years 2012, 2020 & 2027

IRAN
Table 54: Iran Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 55: Iran Historic Review for Percutaneous Nephrolithotomy
by Segment - Percutaneous Nephrolithotomy Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

ISRAEL
Table 56: Israel Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 57: Israel Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

SAUDI ARABIA
Table 58: Saudi Arabia Current & Future Analysis for
Percutaneous Nephrolithotomy by Segment - Percutaneous
Nephrolithotomy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 59: Saudi Arabia Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

UNITED ARAB EMIRATES
Table 60: UAE Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 61: UAE Historic Review for Percutaneous Nephrolithotomy
by Segment - Percutaneous Nephrolithotomy Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

REST OF MIDDLE EAST
Table 62: Rest of Middle East Current & Future Analysis for
Percutaneous Nephrolithotomy by Segment - Percutaneous
Nephrolithotomy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 63: Rest of Middle East Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

AFRICA
Table 64: Africa Current & Future Analysis for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: Africa Historic Review for Percutaneous
Nephrolithotomy by Segment - Percutaneous Nephrolithotomy
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

IV. COMPETITION
Total Companies Profiled: 42
Read the full report: https://www.reportlinker.com/p06032472/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001